Vewinger, N.; Huprich, S.; Seidmann, L.; Russo, A.; Alt, F.; Bender, H.; Sommer, C.; Samuel, D.; Lehmann, N.; Backes, N.;
et al. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients. Int. J. Mol. Sci. 2019, 20, 3027.
https://doi.org/10.3390/ijms20123027
AMA Style
Vewinger N, Huprich S, Seidmann L, Russo A, Alt F, Bender H, Sommer C, Samuel D, Lehmann N, Backes N,
et al. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients. International Journal of Molecular Sciences. 2019; 20(12):3027.
https://doi.org/10.3390/ijms20123027
Chicago/Turabian Style
Vewinger, Nadine, Sabrina Huprich, Larissa Seidmann, Alexandra Russo, Francesca Alt, Hannah Bender, Clemens Sommer, David Samuel, Nadine Lehmann, Nora Backes,
and et al. 2019. "IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients" International Journal of Molecular Sciences 20, no. 12: 3027.
https://doi.org/10.3390/ijms20123027
APA Style
Vewinger, N., Huprich, S., Seidmann, L., Russo, A., Alt, F., Bender, H., Sommer, C., Samuel, D., Lehmann, N., Backes, N., Roth, L., Harter, P. N., Filipski, K., Faber, J., & Paret, C.
(2019). IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients. International Journal of Molecular Sciences, 20(12), 3027.
https://doi.org/10.3390/ijms20123027